Retrospective Study of Safety and Efficacy in Phase I Oncology Trials

Retrospective Study of Safety and Efficacy in Phase I Oncology Trials - Retrospective Study of Safety and Efficacy in Phase I Oncology Trials

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042487

Enrollment

4000

Registered

2020-11-18

Start date

2014-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: We define patients who were considered or participated in phase I clinical trials between January 1, 1995, and September 30, 2024, at the National Cancer Center Hospital.

Exclusion criteria

Exclusion criteria: Nothing specific

Design outcomes

Primary

Measure	Time frame
Anti-tumor effect	—

Secondary

Measure	Time frame
Age, Performance Status, cancer type, genetic variants, stage, comorbidities, Investigational drug, serious adverse event, progression-free survival, date of study entry, start date, date of withdrawal, date of treatment end, date of death, or final follow-up date, and etc.	—

Countries

Japan

Contacts

Public ContactTakafumi Koyama

National Cancer Center Hospital Department of Experimental Therapeutics

takoyama@ncc.go.jp03-3542-2511

Outcome results